TPH vs. PBYI

Last updated Apr 1, 2026

Compare and contrast key facts about Tri Pointe Homes, Inc. (TPH) and Puma Biotechnology, Inc. (PBYI).

Performance

TPH vs. PBYI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Tri Pointe Homes, Inc. (TPH) and Puma Biotechnology, Inc. (PBYI). The values are adjusted to include any dividend payments, if applicable.

TPH vs. PBYI - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
TPH Tri Pointe Homes, Inc.	48.49%	-13.21%	2.43%	90.42%	-33.35%	61.68%	10.72%	42.54%	-39.01%	56.10%
PBYI Puma Biotechnology, Inc.	7.39%	95.08%	-29.56%	2.36%	39.14%	-70.37%	17.26%	-57.00%	-79.41%	221.99%

Fundamentals

Market Cap TPH : $4.02B PBYI : $329.22M
EPS TPH : $3.26 PBYI : $0.61
PE Ratio TPH : 14.35 PBYI : 10.46
PS Ratio TPH : 1.23 PBYI : 1.42
PB Ratio TPH : 1.21 PBYI : 2.53
Total Revenue (TTM) TPH : $3.38B PBYI : $228.42M
Gross Profit (TTM) TPH : -$528.87M PBYI : $170.19M
EBITDA (TTM) TPH : $279.98M PBYI : $49.56M

Returns By Period

In the year-to-date period, TPH achieves a 48.49% return, which is significantly higher than PBYI's 7.39% return. Over the past 10 years, TPH has outperformed PBYI with an annualized return of 14.87%, while PBYI has yielded a comparatively lower -14.09% annualized return.

TPH

• 1D: 0.06%
• 1M: 0.93%
• YTD: 48.49%
• 6M: 37.56%
• 1Y: 46.40%
• 3Y*: 22.66%
• 5Y*: 17.09%
• 10Y*: 14.87%

PBYI

• 1D: 4.24%
• 1M: 12.11%
• YTD: 7.39%
• 6M: 20.34%
• 1Y: 115.88%
• 3Y*: 27.40%
• 5Y*: -8.49%
• 10Y*: -14.09%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

TPH vs. PBYI — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TPH

TPH Risk / Return Rank: 80
TPH Sharpe Ratio Rank: 77
TPH Sortino Ratio Rank: 81
TPH Omega Ratio Rank: 80
TPH Calmar Ratio Rank: 84
TPH Martin Ratio Rank: 79

PBYI

PBYI Risk / Return Rank: 87
PBYI Sharpe Ratio Rank: 86
PBYI Sortino Ratio Rank: 83
PBYI Omega Ratio Rank: 86
PBYI Calmar Ratio Rank: 91
PBYI Martin Ratio Rank: 88

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

TPH vs. PBYI - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Tri Pointe Homes, Inc. (TPH) and Puma Biotechnology, Inc. (PBYI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	TPH	PBYI	Difference
Sharpe ratio Return per unit of total volatility	1.09	1.61	-0.52
Sortino ratio Return per unit of downside risk	2.15	2.26	-0.10
Omega ratio Gain probability vs. loss probability	1.28	1.35	-0.06
Calmar ratio Return relative to maximum drawdown	2.67	4.01	-1.34
Martin ratio Return relative to average drawdown	5.64	9.26	-3.62
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

TPH vs. PBYI - Sharpe Ratio Comparison

The current TPH Sharpe Ratio is 1.09, which is lower than the PBYI Sharpe Ratio of 1.61. The chart below compares the historical Sharpe Ratios of TPH and PBYI, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	TPH	PBYI	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.09	1.61	-0.52
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.45	-0.11	+0.57
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.35	-0.17	+0.53
Sharpe Ratio (All Time) Calculated using the full available price history	0.18	-0.05	+0.22

Correlation

The correlation between TPH and PBYI is 0.21, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

TPH vs. PBYI - Dividend Comparison

Neither TPH nor PBYI has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

TPH vs. PBYI - Drawdown Comparison

The maximum TPH drawdown since its inception was -70.06%, smaller than the maximum PBYI drawdown of -99.40%. Use the drawdown chart below to compare losses from any high point for TPH and PBYI.

Drawdown Indicators

	TPH	PBYI	Difference
Max Drawdown Largest peak-to-trough decline	-70.06%	-99.40%	+29.34%
Max Drawdown (1Y) Largest decline over 1 year	-17.47%	-25.78%	+8.31%
Max Drawdown (5Y) Largest decline over 5 years	-47.00%	-85.86%	+38.86%
Max Drawdown (10Y) Largest decline over 10 years	-68.38%	-98.76%	+30.38%
Current Drawdown Current decline from peak	0.00%	-97.68%	+97.68%
Average Drawdown Average peak-to-trough decline	-24.09%	-74.13%	+50.04%
Ulcer Index Depth and duration of drawdowns from previous peaks	8.28%	11.17%	-2.89%

Volatility

TPH vs. PBYI - Volatility Comparison

The current volatility for Tri Pointe Homes, Inc. (TPH) is 0.59%, while Puma Biotechnology, Inc. (PBYI) has a volatility of 10.78%. This indicates that TPH experiences smaller price fluctuations and is considered to be less risky than PBYI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	TPH	PBYI	Difference
Volatility (1M) Calculated over the trailing 1-month period	0.59%	10.78%	-10.19%
Volatility (6M) Calculated over the trailing 6-month period	30.90%	53.16%	-22.26%
Volatility (1Y) Calculated over the trailing 1-year period	42.75%	72.70%	-29.95%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	37.87%	75.96%	-38.09%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	42.10%	81.23%	-39.13%

Financials